Oncogenic Ras and constitutively activated Akt promote multiple myeloma cell survival independently of each other

被引:0
|
作者
Steinbrunn, T. [1 ]
Stuehmer, T. [1 ]
Chatterjee, M. [1 ]
Gattenloehner, S. [2 ]
Einsele, H. [1 ]
Bargou, R. [1 ]
机构
[1] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[2] Univ Klinikum Wurzburg, Inst Pathol, Wurzburg, Germany
来源
ONKOLOGIE | 2010年 / 33卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:282 / 283
页数:2
相关论文
共 38 条
  • [1] Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival
    Steinbrunn, Torsten
    Stuehmer, Thorsten
    Gattenloehner, Stefan
    Rosenwald, Andreas
    Mottok, Anja
    Unzicker, Christian
    Einsele, Hermann
    Chatterjee, Manik
    Bargou, Ralf C.
    BLOOD, 2011, 117 (06) : 1998 - 2004
  • [2] RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS
    Seibold, Marcel
    Stuehmer, Thorsten
    Kremer, Nadine
    Mottok, Anja
    Scholz, Claus-Juergen
    Schlosser, Andreas
    Leich, Ellen
    Holzgrabe, Ulrike
    Bruennert, Daniela
    Barrio, Santiago
    Kortuem, K. Martin
    Solimando, Antonio G.
    Chatterjee, Manik
    Einsele, Hermann
    Rosenwald, Andreas
    Bargou, Ralf C.
    Steinbrunn, Torsten
    HAEMATOLOGICA, 2020, 105 (09) : 2316 - 2326
  • [3] RAL Mediates Multiple Myeloma Cell Survival Independently of Oncogenic RAS
    Seibold, Marcel
    Stuehmer, Thorsten
    Kremer, Nadine
    Mottok, Anja
    Scholz, Claus J.
    Bruennert, Daniela
    Chatterjee, Manik
    Leich, Ellen
    Schlosser, Andreas
    Rosenwald, Andreas
    Einsele, Hermann
    Bargou, Ralf C.
    Steinbrunn, Torsten
    BLOOD, 2017, 130
  • [4] DEPLETION OF ONCOGENIC RAS ISOFORMS IMPAIRS SURVIVAL OF MULTIPLE MYELOMA (MM) INDEPENDENTLY OF AKT/PKB SIGNALING
    Steinbrunn, T.
    Stuehmer, T.
    Chatterjee, M.
    Gattenloehner, S.
    Einsele, H.
    Bargou, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 134 - 134
  • [5] RALA AND RALB MEDIATE CELL SURVIVAL INDEPENDENTLY OF ONCOGENIC RAS AND PROVIDE POTENTIAL THERAPEUTIC TARGETS IN MULTIPLE MYELOMA
    Seibold, M.
    Stuehmer, T.
    Schmiedl, N.
    Bruennert, D.
    Mottok, A.
    Leich, E.
    Rosenwald, A.
    Scholz, C. -J.
    Chatterjee, M.
    Einsele, H.
    Bargou, R. C.
    Steinbrunn, T.
    HAEMATOLOGICA, 2017, 102 : 771 - 772
  • [6] RalA and RalB are Potential Therapeutic Targets in Multiple Myeloma Which Mediate Cell Survival Independently of Oncogenic RAS
    Steinbrunn, Torsten
    Seibold, Marcel
    Stuehmer, Thorsten
    Schmiedl, Nadine
    Mottok, Anja
    Leich, Ellen
    Scholz, Claus
    Chatterjee, Manik
    Rosenwald, Andreas
    Einsele, Hermann
    Bargou, Ralf C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E110 - E110
  • [7] Ral contributes to multiple myeloma cell survival and is independent of oncogenic RAS
    Seibold, M.
    Stuehmer, T.
    Schmiedl, N.
    Bruennert, D.
    Mottok, A.
    Leich, E.
    Rosenwald, A.
    Scholz, C. J.
    Chatterjee, M.
    Einsele, H.
    Bargou, R. C.
    Steinbrunn, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 105 - 105
  • [8] Analysis of PKB/Akt-Signaling and Oncogenic Ras in Multiple Myeloma
    Steinbrunn, Torsten
    Stuehmer, Thorsten
    Chatterjee, Manik
    Gattenloehner, Stefan
    Bargou, Ralf C.
    BLOOD, 2009, 114 (22) : 343 - 343
  • [9] Activated Ral and Mutated RAS Are Independent Drivers of Multiple Myeloma Cell Survival.
    Seibold, Marcel
    Stuehmer, Thorsten
    Mottok, Anja
    Scholz, Claus J.
    Chatterjee, Manik
    Leich, Ellen
    Kortuem, Martin
    Schlosser, Andreas
    Einsele, Hermann
    Rosenwald, Andreas
    Bargou, Ralf C.
    Steinbrunn, Torsten
    BLOOD, 2018, 132
  • [10] Mature Osteoblasts Promote Multiple Myeloma Survival through Cell-Cell Contact and Immune Modulation Mechanisms
    Fulzele, Keertik
    Panaroni, Cristina
    Mukaihara, Kenta
    Mori, Tomoaki
    Chattopadhyay, Shrikanta
    Raje, Noopur S.
    BLOOD, 2019, 134